Jhoo JH - Search Results

1

What is the impact of one's chronic illness on his or her spouse's future chronic illness: a community-based prospective cohort study.

An H, Yang HW, Oh DJ, Lim E, Shin J, Moon DG, Suh SW, Byun S, Kim TH, Kwak KP, Kim BJ, Kim SG, Kim JL, Moon SW, Park JH, Ryu SH, Lee DW, Lee SB, Lee JJ, Jhoo JH, Bae JB, Han JW, Kim KW. An H, et al. Among authors: jhoo jh. BMC Med. 2023 Oct 16;21(1):367. doi: 10.1186/s12916-023-03061-9. BMC Med. 2023. PMID: 37840129 Free PMC article.

2

Selegiline potentiates the effects of EGb 761 in response to ischemic brain injury.

Kwon YS, Ann HS, Nabeshima T, Shin EJ, Kim WK, Jhoo JH, Jhoo WK, Wie MB, Kim YS, Jang KJ, Kim HC. Kwon YS, et al. Among authors: jhoo jh, jhoo wk. Neurochem Int. 2004 Jul;45(1):157-70. doi: 10.1016/j.neuint.2003.10.005. Neurochem Int. 2004. PMID: 15082233

3

PAP 9704, a Korean herbal medicine attenuates methamphetamine-induced hyperlocomotion via adenosine A2A receptor stimulation in mice.

Kwon YS, Nabeshima T, Shin EJ, Chun W, Jhoo JH, Jhoo WK, Wie MB, Jang CG, Chung H, Sung YE, Kim HC. Kwon YS, et al. Among authors: jhoo jh, jhoo wk. Biol Pharm Bull. 2004 Jun;27(6):906-9. doi: 10.1248/bpb.27.906. Biol Pharm Bull. 2004. PMID: 15187444 Free article.

4

Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice.

Shin EJ, Nabeshima T, Lee PH, Kim WK, Ko KH, Jhoo JH, Jhoo WK, Cha JY, Kim HC. Shin EJ, et al. Among authors: jhoo jh, jhoo wk. Behav Brain Res. 2004 May 5;151(1-2):267-76. doi: 10.1016/j.bbr.2003.09.004. Behav Brain Res. 2004. PMID: 15084442

5

Protection against kainate neurotoxicity by pyrrolidine dithiocarbamate.

Shin EJ, Jhoo JH, Kim WK, Jhoo WK, Lee C, Jung BD, Kim HC. Shin EJ, et al. Among authors: jhoo jh, jhoo wk. Clin Exp Pharmacol Physiol. 2004 May-Jun;31(5-6):320-6. doi: 10.1111/j.1440-1681.2004.03990.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15191405

6

Antioxidant propolis attenuates kainate-induced neurotoxicity via adenosine A1 receptor modulation in the rat.

Kwon YS, Park DH, Shin EJ, Kwon MS, Ko KH, Kim WK, Jhoo JH, Jhoo WK, Wie MB, Jung BD, Kim HC. Kwon YS, et al. Among authors: jhoo jh, jhoo wk. Neurosci Lett. 2004 Jan 30;355(3):231-5. doi: 10.1016/j.neulet.2003.10.075. Neurosci Lett. 2004. PMID: 14732473

7

Growth hormone releaser attenuates beta-amyloid (1 - 42)-induced memory impairment in mice.

Shin EJ, Jhoo JH, Nabeshima T, Jhoo WK, Kwon MS, Lim YK, Chae JS, Jung ME, Park SJ, Jang KJ, Kim HC. Shin EJ, et al. Among authors: jhoo jh, jhoo wk. J Pharmacol Sci. 2005 Sep;99(1):117-20. doi: 10.1254/jphs.sc0050105. Epub 2005 Sep 1. J Pharmacol Sci. 2005. PMID: 16141634 Free article.

8

CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population.

Woo SI, Kim JW, Seo HG, Park CH, Han SH, Kim SH, Kim KW, Jhoo JH, Woo JI. Woo SI, et al. Among authors: jhoo jh. Psychiatry Clin Neurosci. 2001 Aug;55(4):373-7. doi: 10.1046/j.1440-1819.2001.00877.x. Psychiatry Clin Neurosci. 2001. PMID: 11442888 Free article.

9

The prevalence of dementia in older people in an urban population of Korea: the Seoul study.

Lee DY, Lee JH, Ju YS, Lee KU, Kim KW, Jhoo JH, Yoon JC, Ha J, Woo JI. Lee DY, et al. Among authors: jhoo jh. J Am Geriatr Soc. 2002 Jul;50(7):1233-9. doi: 10.1046/j.1532-5415.2002.50310.x. J Am Geriatr Soc. 2002. PMID: 12133018

10

Development of the Korean version of Alzheimer's Disease Assessment Scale (ADAS-K).

Youn JC, Lee DY, Kim KW, Lee JH, Jhoo JH, Lee KU, Ha J, Woo JI. Youn JC, et al. Among authors: jhoo jh. Int J Geriatr Psychiatry. 2002 Sep;17(9):797-803. doi: 10.1002/gps.699. Int J Geriatr Psychiatry. 2002. PMID: 12221651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page